Home/Filings/4/0000950170-25-081715
4//SEC Filing

Klassen Preston 4

Accession 0000950170-25-081715

CIK 0001505512other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 5:00 PM ET

Size

4.4 KB

Accession

0000950170-25-081715

Insider Transaction Report

Form 4
Period: 2025-06-03
Klassen Preston
DirectorPresident & Head of R & D
Transactions
  • Purchase

    Common Stock

    2025-06-03$7.99/sh+12,000$95,85248,055 total

Documents

1 file

Issuer

Regulus Therapeutics Inc.

CIK 0001505512

Entity typeother

Related Parties

1
  • filerCIK 0001493056

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:00 PM ET
Size
4.4 KB